Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Psoriasis × Methotrexate × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Leukemia 35 Breast Neoplasms 24 Lymphoma 15 Leukemia, Myeloid, Acute 14 Burkitt Lymphoma 11 Myelodysplastic Syndromes 10 Graft vs Host Disease 9 Urinary Bladder Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Osteosarcoma 4 Leukemia, Promyelocytic, Acute 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia, Biphenotypic, Acute 4 Head and Neck Neoplasms 4 Anemia, Refractory, with Excess of Blasts 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Accelerated Phase 3 Hodgkin Disease 3 Dendritic Cell Sarcoma, Interdigitating 3 Arthritis, Rheumatoid 3 Urethral Neoplasms 2 Sarcoma 2 Rhabdoid Tumor 2

Interventions

tofacitinib 6 Etanercept 3 Adalimumab 2 secukinumab 1 apremilast 1 Methotrexate 1 Anti-Infective Agents, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02196701 2018-03-19

CLEAR

AbbVie

Phase 3 Completed

46 enrolled 27 charts

Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡